Clinical trial

Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Low Back…

NCT00346047 · Mundipharma K.K., Industry · Completed

Key facts

NCT number NCT00346047
Title Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Low Back Pain
Official title A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Determine the Efficacy and Safety of BTDS Compared to Placebo in Subjects With Moderate to Severe Low Back Pain
Lead sponsor Mundipharma K.K., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Low Back Pain
Intervention type Drug
Interventions Placebo, Buprenorphine Transdermal System
Enrollment 238
Start date May 1, 2006
Primary completion Jul 1, 2007
Completion Jul 1, 2007
First posted Jun 29, 2006
Last update posted Apr 15, 2008
Countries Japan

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies